bpc-157 fda status Approval Status: Is It Approved for Human Use? FDA advisory committee recommends BPC-157

For example, the antibiotic chloramphenicol can interfere with the effects of vitamin B, reducing the expected hematologic response to B therapy

Not for human or veterinary, diagnostic, or therapeutic use

A more recent Phase I safety trial on healthy volunteers was started in 2015 but puzzlingly, the researchers never published the results , and the trial record was marked completed with no data release

Scientific References Pickart, L

[Google Scholar] Orhan Kili B., Kili S., ahin Erolu E., Gl E., Belen Apak F

A rat wound healing study showed GHK treatment achieved 64.5% reduction in wound size compared to 45.6% for vehicle-treated and 28.2% for untreated controls